cirazoline


SMILES C1CN=C(N1)COc1ccccc1C1CC1
InChIKey YAORIDZYZDUZCM-UHFFFAOYSA-N

Chemical properties

Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 4
Molecular weight (Da) 216.1

Drug properties

Molecular type Small molecule
Endogenous/Surrogate Surrogate
Approved drug Yes

Database connections

Ligand site mutations α1A α1B

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
OT OXYR Human Vasopressin and oxytocin A pKi 6.0 6.8 7.6 Guide to Pharmacology
V1B V1BR Human Vasopressin and oxytocin A pKi 6.2 6.4 6.6 Guide to Pharmacology
V1A V1AR Human Vasopressin and oxytocin A pKi 8.33 9.12 9.82 ChEMBL
V1A V1AR Human Vasopressin and oxytocin A pKi 8.3 8.4 8.5 Guide to Pharmacology
V1B V1BR Human Vasopressin and oxytocin A pKi 7.36 7.36 7.36 ChEMBL
V2 V2R Human Vasopressin and oxytocin A pKi 6.48 6.48 6.48 ChEMBL
V2 V2R Human Vasopressin and oxytocin A pKi 5.5 5.75 6.0 Guide to Pharmacology
OT OXYR Human Vasopressin and oxytocin A pKi 6.4 7.37 7.96 ChEMBL
OT OXYR Rat Vasopressin and oxytocin A pKd 8.29 8.29 8.29 ChEMBL
OT OXYR Rat Vasopressin and oxytocin A pKi 7.12 7.26 7.4 ChEMBL
OT OXYR Rat Vasopressin and oxytocin A pKi 7.1 7.1 7.1 Guide to Pharmacology
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
OT OXYR Human Vasopressin and oxytocin A pIC50 6.43 6.83 7.23 ChEMBL
OT OXYR Rat Vasopressin and oxytocin A pIC50 7.92 7.92 7.92 ChEMBL